Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProtectLife International Biomedical is a medical device company specializing in the development and manufacture of point-of-care testing (POCT) and in-vitro diagnostic (IVD) systems. The company utilizes proprietary microfluidic disc technology to provide rapid, laboratory-quality clinical chemistry results from small sample volumes. Its product portfolio includes the AmiShield analyzer for veterinary diagnostics and the EnTrust analyzer for human clinical use, supported by a wide range of multi-parameter reagent discs. Headquartered in Taiwan, ProtectLife focuses on decentralizing healthcare by providing accessible diagnostic solutions for clinics, emergency rooms, and remote locations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProtectLife International Biomedical.